Document Type : Original Article
Authors
1 Associate Professor, Department of Anesthesia, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 Associate Professor, Department of Epidemiology , School of Health, Mashhad University of Medical Sciences, Mashhad, Iran
3 Anesthesiologist, Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Keywords
Acknowledgements: The authors sincerely appreciate the support and collaboration of colleagues, medical staff, and all those who contributed to this study. Their assistance and insights were invaluable in completing this research.
Availability of data and materials: The data and materials related to this study are available from the corresponding author, Naser Naderi, upon reasonable request.
Conflicts of interests: The authors declare that they have no conflicts of interest.
Consent for publication: Not Applicable
Ethics approval and consent to participate: This study was conducted based on research project No. 990848, approved on 2020/10/03, and the ethics committee approval No. IR.MUMS.MEDICAL.REC.1399.580, approved on 2020/11/17, with the title: "Using high-dose Sufentanil intrathecally for painless induction and postoperative pain management in gastrointestinal cancer surgeries." Additionally, the study adhered to the principles outlined in the Declaration of Helsinki.
Financial disclosure: The authors declare that no financial support, grants, or funding was received for the research, authorship, and/or publication of this manuscript.
Author contributions: All authors contributed equally to the research, writing, and revision of this manuscript.
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/